Compliance information - AIM Rule 26
The following information is disclosed in accordance with Rule 26 of the AIM Rules (February 2007), “Each AIM company must from admission maintain a website on which the following information should be available, free of charge”:
A description of its business and, where it is
an investing company, its investing strategy;
Please click on the link below for a description of the
business.
About Neuropharm
Last Updated: 16 Aug 2007
The names of its directors and brief biographical details of
each, as would normally be included in an admission
document;
A description of the responsibilities of the members of the
board of directors and details of any committees of the board of
directors and their responsibilities;
Please click on the link below for the names of Neuropharm Group
plc’s directors, their brief biographical details, description of
responsibilities and membership of any committees.
Board of Directors
Last Updated: 9 Apr 2010
Its country of incorporation and main country of
operation;
Neuropharm Group plc is incorporated in England (Registration
Number 5983736), which is also its main country of operation.
Last Updated: 16 Aug 2007
Where the AIM company is not incorporated in the UK, a
statement that the rights of shareholders may be different from the
rights of shareholders in a UK incorporated company;
The company is incorporated in the UK.
Last Updated: 16 Aug 2007
Its current constitutional documents (e.g. its articles of
association);
Please click on the link below for Neuropharm Group plc’s current
constitutional documents.
Corporate Governance
Last Updated: 9 Dec 2009
Details of any other exchanges or trading platforms on which
the AIM company has applied or agreed to have any of its securities
(including its AIM securities) admitted or traded;
The company is not listed on any other exchanges or trading
platforms.
Last Updated: 16 Aug 2007
The number of AIM securities in issue (noting any held as
treasury shares) and, insofar as it is aware, the percentage of AIM
securities that is not in public hands together with the identity
and percentage holdings of its significant shareholders;
Please click on the link below for details of the number of
securities in issue, together with the identity and percentage
holdings of our significant shareholders.
Significant shareholders
Last Updated: 8 Dec 2009
Details of any restrictions on the transfer of its AIM
securities;
There are no restrictions on the transfer of securities.
Last Updated: 16 Aug 2007
Its most recent annual report published pusuant to rule 19
and all half-yearly, quarterly or similar reports published since
the last annual report pursuant to rule 18;
Annual & Interim reports
Last Updated: 23 Mar 2010
All notifications the AIM company has made in the past 12
months;
Regulatory announcements
Last Updated: Automatic update from RNS news service
Its most recent admission document together with any
circulars or similar publications sent to shareholders within the
past 12 months;
Admission Document PDF -
(736.8KB)
Last Updated: 20 Apr 2010
Details of its nominated adviser and other key advisers (as
might normally be found in an admission document).
Please click on the link below for details of the company’s
Nominated Advisor and other key advisors.
Advisors
Last Updated: 23 Sep 2008